SSY Group (HKSE:02005) Interest Expense : HK$-125 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is SSY Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. SSY Group's interest expense for the six months ended in Dec. 2023 was HK$ -65 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-125 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. SSY Group's Operating Income for the six months ended in Dec. 2023 was HK$ 881 Mil. SSY Group's Interest Expense for the six months ended in Dec. 2023 was HK$ -65 Mil. SSY Group's Interest Coverage for the quarter that ended in Dec. 2023 was 13.62. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SSY Group Interest Expense Historical Data

The historical data trend for SSY Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Interest Expense Chart

SSY Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-55.27

-51.47

-61.30

-88.25

-125.41

SSY Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-32.29	-37.88	-50.37	-60.75	-64.67

SSY Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-125 Mil.

SSY Group (HKSE:02005) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SSY Group's Interest Expense for the six months ended in Dec. 2023 was HK$-65 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$881 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$1,951 Mil.

SSY Group's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	880.675	/	-64.665
	=	13.62

The higher the ratio, the stronger the company's financial strength is.

SSY Group (HKSE:02005) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG

Website

http://www.ssygroup.com.hk

SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

SSY Group (HKSE:02005) Headlines

No Headlines